Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007-Reference-Cited by-同舟云学术

Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007

Published:2018-02 Issue:10 Volume:36 Page:1297-1303
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Norheim Gunnstein,Mueller Judith E.,Njanpop-Lafourcade Berthe-Marie,Delrieu Isabelle,Findlow Helen,Borrow Ray,Xie Ouli,Nagaputra Jerry,Ramasamy Roshan,Dold Christina,Tamekloe Tsidi Agbeko,Rollier Christine S.,Watt Hilary,Kere Abiba Banla,Næss Lisbeth M.,Pollard Andrew J.

Funder

Meningitis Research Foundation, U.K.

Oxford Partnership Comprehensive Biomedical Research Centre

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference44 articles.

1. Cerebrospinal meningitis in Africa;Lapeyssonnie;Bull World Health Organ,1963

2. Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa;Molesworth;Trans R Soc Trop Med Hyg,2002

3. Manson Lecture. Meningococcal meningitis in Africa;Greenwood;Trans R Soc TropMed Hyg,1999

4. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger;Boisier;Clin Infect Dis,2007

5. Serogroup X meningococcal disease, Western Kenya;Materu;Emerg Infect Dis,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates;Vaccine;2020-11

2. Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study;The Lancet Infectious Diseases;2018-10